Organovo to Present at 28th Annual Piper Jaffray Healthcare Conference
23 November 2016 - 12:05AM
Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a
three-dimensional biology company focused on delivering scientific
and medical breakthroughs using its 3D bioprinting technology,
today announced that Chairman and Chief Executive Officer Keith
Murphy is scheduled to speak at the 28th Annual Piper Jaffray
Healthcare Conference in New York on Tuesday, November 29th at 4:00
p.m. Eastern Time (ET). The presentation will be
simultaneously audio webcast at http://www.organovo.com. The
audio webcast will be archived for 90 days following the
conference.
About Organovo Holdings,
Inc.Organovo designs and creates functional,
three-dimensional human tissues for use in medical research and
therapeutic applications. The Company develops 3D human
tissue models through internal development and in collaboration
with pharmaceutical, academic and other partners.
Organovo's 3D human tissues have the potential to accelerate
the drug discovery process, enabling treatments to be developed
faster and at lower cost. The Company’s ExVive Human Liver
and Kidney Tissues are used in toxicology and other preclinical
drug testing. The Company also actively conducts early
research on specific tissues for therapeutic use in direct surgical
applications. In addition to numerous scientific
publications, the Company’s technology has been featured
in The Wall Street Journal, Time Magazine, The Economist,
Forbes, and numerous other media outlets. Organovo is
changing the shape of life science research and transforming
medical care. Learn more at www.organovo.com.
Investor Contact:
Steve Kunszabo
Organovo Holdings, Inc.
+1 (858) 224-1092
skunszabo@organovo.com
Press Contact:
Jessica Yingling
Little Dog Communications
+1 (858) 480-2411
jessica@litldog.com
Organovo (NASDAQ:ONVO)
Historical Stock Chart
From Apr 2024 to May 2024
Organovo (NASDAQ:ONVO)
Historical Stock Chart
From May 2023 to May 2024